Generation of genetically-altered mice producing very low levels of coagulation factor VII
Elliot D. Rosen 1,2,4, Haifeng Xu 1,2, Zhong Liang1,4, J. Andrew Martin1,2, Mark Suckow 3 , Francis J. Castellino 1,2
1 W. M. Keck Center for Transgene Research, 2 Department of Chemistry and Biochemistry, and 3 Friemann Life Science Center, University of Notre Dame, Notre Dame, Indiana, USA, the 4 Department of Medical and Molecular Genetics and Indiana Center for Vasc
Summary
It has been shown earlier that mice with a total targeted deletionof the factorVII gene (FVII-/- ) die perinatally,thereby precludingstudy of adult animals with this total deficiency. Consequently,mice producing very low levels of FVII were developedby targeted replacement of the wild-type (WT) murineFVII gene with its corresponding cDNA,under control of the tetracyclinetransactivator (tTA) promoter. When backcrossedinto the C57Bl/6 strain, unchallenged mice containing two replaced FVIItTA alleles (FVIItTA/tTA ) produce approximately 0.7% ofWT FVII levels, but yet live to adulthood despite displaying severelydownregulated overall thrombin production and spontaneouslydeveloping cardiac fibrosis at a young adult age.This genetically-altered mouse line provides an excellent animal modelto study consequences of a severe FVII deficiency in unchallengedmice and in mice subjected to a variety of experimentalchallenges. DOI
http://dx.doi.org/10.1160/TH05-05-0337